Pharmaceutical equivalence and dissolution profile studies for tablets containing hydrochlorothiazide

Authors

  • Cássio Carvalho Ribeiro Departamento de Ciências Farmacêuticas, Centro de Ciências da Saúde, Universidade Estadual de Londrina (UEL), Av. Robert Koch, n. 60, Vila Operária, Londrina, CEP: 86038-350, PR. Telefone: +55 43 3371 2475
  • Giovana Maria Marques Andrade Departamento de Ciências Farmacêuticas, Centro de Ciências da Saúde, Universidade Estadual de Londrina (UEL), Av. Robert Koch, n. 60, Vila Operária, Londrina, CEP: 86038-350, PR. Telefone: +55 43 3371 2475
  • Renê Oliveira Couto Departamento de Ciências Farmacêuticas, Centro de Ciências da Saúde, Universidade Estadual de Londrina (UEL), Av. Robert Koch, n. 60, Vila Operária, Londrina, CEP: 86038-350, PR. Telefone: +55 43 3371 2475 http://orcid.org/0000-0002-3748-3427

DOI:

https://doi.org/10.14450/2318-9312.v30.e1.a2018.pp5-13

Keywords:

hydrochlorthiazide, quality control, tablets, generic, dissolution

Abstract

Hydrochlorothiazide (HCTZ) belongs to the thiazide diuretic class, widely used in the treatment of patients with mild to moderate edema and systemic arterial hypertension, being considered highly effective by health professionals. The
purpose of this work was to evaluate the pharmaceutical equivalence and to perform comparative dissolution profile studies between the Reference medicine (R) and three Generic medicines from different brands (G1, G2 and G3)
presented as immediate release tablets of hydrochlorothiazide (25 mg). Such studies were carried out according to the monograph presented in the Brazilian Pharmacopoeia 5th Ed. (2010) and the current national legislation. In the physical and physicochemical tests, G1, G2 and G3 were approved. However, in some cases they presented significant differences when compared to R. Regarding the dissolution profile, which aims to evaluate the similarity factor (F2), only G3 did not present similar profile as compared to R. Thereby, interchangeability between G3 and R may be impaired once the drug may not reach the required plasmatic levels at the desired absorption rate and extension. Data arising from this study may reflect the quality and reliability of the generic medicines widely used from the Brazilian population.

Author Biography

Renê Oliveira Couto, Departamento de Ciências Farmacêuticas, Centro de Ciências da Saúde, Universidade Estadual de Londrina (UEL), Av. Robert Koch, n. 60, Vila Operária, Londrina, CEP: 86038-350, PR. Telefone: +55 43 3371 2475

Ciências Farmacêuticas

Downloads

Published

2018-04-09

How to Cite

Ribeiro, C. C., Andrade, G. M. M., & Couto, R. O. (2018). Pharmaceutical equivalence and dissolution profile studies for tablets containing hydrochlorothiazide. Infarma - Pharmaceutical Sciences, 30(1), 5–13. https://doi.org/10.14450/2318-9312.v30.e1.a2018.pp5-13

Issue

Vol. 30 No. 1 (2018)

Section

Original article

License

Authors who publish in this journal agree to the following terms:

 

  1. Authors retain the copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Licença Creative Commons Attribution which allows the sharing of work with acknowledgment of authorship and initial publication in this journal.
  2. Authors are authorized to take additional contracts separately, for non-exclusive distribution of the version of the work published in this journal (e.g. publish in institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal.
  3. Authors are allowed and encouraged to publish and distribute their work online (e.g. in institutional repositories or on their personal page) at any point before or during the editorial process, as this can generate productive changes as well as increase the impact and Citation of published work (See O Efeito do Acesso Livre ).